CL2013001330A1 - Virus aislado con arn de cadena positiva y que carece de envoltura; secuencia de acido nucleico que codifica dicho virus; vector, celula ; anticuerpo; composición inmunogénica que comprende dicho virus; metodo de detección de un virus. - Google Patents

Virus aislado con arn de cadena positiva y que carece de envoltura; secuencia de acido nucleico que codifica dicho virus; vector, celula ; anticuerpo; composición inmunogénica que comprende dicho virus; metodo de detección de un virus.

Info

Publication number
CL2013001330A1
CL2013001330A1 CL2013001330A CL2013001330A CL2013001330A1 CL 2013001330 A1 CL2013001330 A1 CL 2013001330A1 CL 2013001330 A CL2013001330 A CL 2013001330A CL 2013001330 A CL2013001330 A CL 2013001330A CL 2013001330 A1 CL2013001330 A1 CL 2013001330A1
Authority
CL
Chile
Prior art keywords
virus
lacking
sheath
antibody
nucleic acid
Prior art date
Application number
CL2013001330A
Other languages
English (en)
Inventor
Pal Nilsen
Marianne Froystad-Saugen
Karine Lindmo
Aase Beathe Mikalsen
Oystein Evensen
Marit Rode
Original Assignee
Pharmaq As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46083543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001330(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmaq As filed Critical Pharmaq As
Publication of CL2013001330A1 publication Critical patent/CL2013001330A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CL2013001330A 2010-11-15 2013-05-14 Virus aislado con arn de cadena positiva y que carece de envoltura; secuencia de acido nucleico que codifica dicho virus; vector, celula ; anticuerpo; composición inmunogénica que comprende dicho virus; metodo de detección de un virus. CL2013001330A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20101604 2010-11-15

Publications (1)

Publication Number Publication Date
CL2013001330A1 true CL2013001330A1 (es) 2014-05-23

Family

ID=46083543

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013001330A CL2013001330A1 (es) 2010-11-15 2013-05-14 Virus aislado con arn de cadena positiva y que carece de envoltura; secuencia de acido nucleico que codifica dicho virus; vector, celula ; anticuerpo; composición inmunogénica que comprende dicho virus; metodo de detección de un virus.

Country Status (5)

Country Link
EP (1) EP2640832B1 (es)
CA (1) CA2817933A1 (es)
CL (1) CL2013001330A1 (es)
NO (1) NO2640832T3 (es)
WO (1) WO2012066481A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO344698B1 (en) * 2018-06-15 2020-03-09 Patogen As Novel fish virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
CA2570050C (en) * 2004-06-11 2013-03-05 Pharmaq As Heart and skeletal muscle inflammation (hsmi) virus
GB2452363B (en) 2007-06-28 2012-08-08 Pharmaq As Novel fish pathogen

Also Published As

Publication number Publication date
NO2640832T3 (es) 2018-05-19
CA2817933A1 (en) 2012-05-24
EP2640832A1 (en) 2013-09-25
WO2012066481A1 (en) 2012-05-24
EP2640832A4 (en) 2014-11-12
EP2640832B1 (en) 2017-12-20

Similar Documents

Publication Publication Date Title
BR112012024287A2 (pt) anticorpo, composição farmacêutica, método, ácido nucleico, vetor de expressão e célula hospedeira
WO2013006756A3 (en) Alpha amylase variants and polynucleotides encoding same
WO2014177546A3 (en) Glucoamylase variants and polynucleotides encoding same
CL2014003131A1 (es) Una proteína de unida al antígeno st2; acido nucleico que la codifica; y sus usos.
WO2013057141A3 (en) Alpha-amylase variants and polynucleotides encoding same
HK1215954A1 (zh) 蛋白、核酸、和抗體及其用途
WO2013057143A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX351762B (es) Variantes de glucoamilasas y polinucleotidos que las codifican.
BR112013020070A2 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
WO2012044915A3 (en) Beta-glucosidase variants and polynucleotides encoding same
BR112012022046A2 (pt) ''anticorpo,composição farmacêutica,ácido nucleico ,vetores de expressão,célula hospedeira e método para a produção de um anticorpo recombinante''.
BR112013018311A2 (pt) sequência de ácido nucleico isolada, receptor de antígeno quimérico isolado, célula t geneticamente modificada, vetor, e, uso de uma célula t geneticamente modificada.
MX351154B (es) Variantes de glucoamilasas y polinucleotidos que las codifican.
WO2013006544A8 (en) Methods for making multimeric polypeptides
BR112013033350A2 (pt) imunocitocina, ácido nucleico, vetor, célula hospedeira e composição farmacêutica
WO2010127304A3 (en) Sequencing methods
BR112013015553A2 (pt) sistema de conversão de biomassa, ,e, método
WO2011142970A3 (en) Her2 nucleic acid aptamers
WO2013119302A3 (en) Gh61 polypeptide variants and polynucleotides encoding same
EP3696265A3 (en) Lipase variants and polynucleotides encoding same
ZA201306009B (en) Nucleic acid molecule encoding hepatitis b virus core protein and vaccine comprising the same
WO2011109524A3 (en) Xylanase variants and polynucleotides encoding same
EP3321360A3 (en) Alpha-amylase variants and polynucleotides encoding same
WO2014195356A3 (en) Alpha-amylase variants and polynucleotides encoding same
WO2014017493A9 (ja) ワクチン